Dolby Labs Files Q1 FY25 10-Q
Ticker: DLB · Form: 10-Q · Filed: Jan 30, 2025 · CIK: 1308547
| Field | Detail |
|---|---|
| Company | Dolby Laboratories, INC. (DLB) |
| Form Type | 10-Q |
| Filed Date | Jan 30, 2025 |
| Risk Level | low |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-filing, financials
TL;DR
Dolby Labs Q1 FY25 10-Q is in. Check financials.
AI Summary
Dolby Laboratories, Inc. filed its 10-Q for the period ending December 27, 2024. The company reported its financial results for the first quarter of fiscal year 2025. Key financial data and business segment information were disclosed in this filing.
Why It Matters
This filing provides investors with the latest financial performance and operational details for Dolby Laboratories, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial disclosures.
Key Players & Entities
- Dolby Laboratories, Inc. (company) — Filer of the 10-Q
- 2024-12-27 (date) — End of reporting period
- 2025-01-30 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended December 27, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed with the SEC on January 30, 2025.
What is the Central Index Key (CIK) for Dolby Laboratories, Inc.?
The Central Index Key (CIK) for Dolby Laboratories, Inc. is 0001308547.
What is the fiscal year end for Dolby Laboratories?
Dolby Laboratories' fiscal year ends on September 27.
What is the SEC file number for Dolby Laboratories?
The SEC file number for Dolby Laboratories is 001-32431.
Filing Stats: 4,396 words · 18 min read · ~15 pages · Grade level 17.3 · Accepted 2025-01-30 16:06:13
Key Financial Figures
- $0.001 — which registered Class A common stock, $0.001 par value DLB The New York Stock Exchan
Filing Documents
- dlb-20241227.htm (10-Q) — 1738KB
- exhibit311-q125.htm (EX-31.1) — 10KB
- exhibit312-q125.htm (EX-31.2) — 11KB
- exhibit321-q125.htm (EX-32.1) — 5KB
- dlb-20241227_g1.jpg (GRAPHIC) — 37KB
- 0001628280-25-003175.txt ( ) — 10264KB
- dlb-20241227.xsd (EX-101.SCH) — 76KB
- dlb-20241227_cal.xml (EX-101.CAL) — 153KB
- dlb-20241227_def.xml (EX-101.DEF) — 317KB
- dlb-20241227_lab.xml (EX-101.LAB) — 888KB
- dlb-20241227_pre.xml (EX-101.PRE) — 591KB
- dlb-20241227_htm.xml (XML) — 1669KB
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
Unaudited Interim Condensed Consolidated Financial Statements
Item 1. Unaudited Interim Condensed Consolidated Financial Statements 4 Unaudited Interim Condensed Consolidated Balance Sheets 4 Unaudited Interim Condensed Consolidated Statements of Operations 5 Unaudited Interim Condensed Consolidated Statements of Comprehensive Income 6 Unaudited Interim Condensed Consolidated Statements of Stockholders' Equity 7 Unaudited Interim Condensed Consolidated Statements of Cash Flows 8 Notes to Unaudited Interim Condensed Consolidated Financial Statements 9
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 33
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 53
Controls and Procedures
Item 4. Controls and Procedures 55
– OTHER INFORMATION
PART II – OTHER INFORMATION
Legal Proceedings
Item 1. Legal Proceedings 56
Risk Factors
Item 1A. Risk Factors 56
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 71
Other Information
Item 5. Other Information 71
Exhibits
Item 6. Exhibits 72 Signature 2 Table of Contents GLOSSARY OF TERMS The following table summarizes certain terms and abbreviations that may be used within the text of this report: Abbreviation Term AAC Advanced Audio Coding AFS Available-For-Sale (Securities) AOCI Accumulated Other Comprehensive Income (Loss) API Application Programming Interface APIC Additional Paid In-Capital ARPU Average Revenue Per Unit ASC Accounting Standards Codification ASU Accounting Standards Update AVC Advanced Video Coding AVR Audio/Video Receiver CE Consumer Electronics CODM Chief Operating Decision Maker COSO Committee Of Sponsoring Organizations (Of The Treadway Commission) DD Dolby Digital DD+ Dolby Digital Plus DMA Digital Media Adapter DTV Digital Television DVD Digital Versatile Disc EPS Earnings Per Share ESP Estimated Selling Price ESPP Employee Stock Purchase Plan FASB Financial Accounting Standards Board FCPA Foreign Corrupt Practices Act G&A General and Administrative HDR High-Dynamic Range HE-AAC High Efficiency Advanced Audio Coding HEVC High Efficiency Video Coding IC Integrated Circuit IBR Incremental Borrowing Rate IP Intellectual Property LP Limited Partner/Partnership NOL Net Operating Loss OECD Organization For Economic Co-Operation & Development OEM Original Equipment Manufacturer OTT Over-The-Top PC Personal Computer PCS Post-Contract Support PP&E Property, Plant, and Equipment PSO Performance-Based Stock Option PSU Performance-Based Restricted Stock Unit R&D Research and Development ROU Right-Of-Use RSU Restricted Stock Unit S&M Sales and Marketing SEC U.S. Securities and Exchange Commission SERP Supplemental Executive Retirement Plan STB Set-Top Box TSR Total Stockholder Return U.S. GAAP Generally Accepted Accounting Principles In The United States VVC Versatile Video Coding 3 Table of Contents
– FINANCIAL INFORMATION
PART I – FINANCIAL INFORMATION
UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 1. UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS DOLBY LABORATORIES, INC. INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS ( in thousands, except share and per share amounts ) (unaudited) December 27, 2024 September 27, 2024 ASSETS Current assets: Cash and cash equivalents $ 520,821 $ 482,047 Restricted cash 90,836 95,705 Accounts receivable, net of allowance for credit losses of $ 5,892 and $ 5,361 339,304 315,465 Contract assets, net of allowance for credit losses of $ 107 and $ 106 220,892 197,478 Inventories, net 31,833 33,728 Prepaid expenses and other current assets 82,113 69,994 Total current assets 1,285,799 1,194,417 Long-term investments 86,304 89,267 Property, plant, and equipment, net 476,113 479,109 Operating lease right-of-use assets 36,972 39,046 Intangible assets, net 421,242 434,514 Goodwill 520,419 533,208 Deferred taxes 227,021 219,758 Other non-current assets 104,732 120,609 Total assets $ 3,158,602 $ 3,109,928 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $ 11,550 $ 17,380 Accrued liabilities 360,915 347,529 Income taxes payable 20,875 9,045 Contract liabilities 37,111 31,644 Operating lease liabilities 11,426 12,238 Total current liabilities 441,877 417,836 Non-current contract liabilities 32,481 34,593 Non-current operating lease liabilities 33,019 34,754 Other non-current liabilities 134,197 135,852 Total liabilities 641,574 623,035 Commitment and Contingencies (See Note 15) Stockholders' equity: Class A, $ 0.001 par value, one vote per share, 500,000,000 shares authorized: 61,193,222 shares issued and outstanding as of December 27, 2024 and 59,722,442 as of September 27, 2024 55 53 Class B, $ 0.001 par value, ten votes per share, 500,000,000 shares authorized: 35,170,779 shares issued and outstanding as of December 27, 2024 and 35,670,779 as of September 27, 2024 40 41 Retained earnings 2,543,413 2,496,255 Accumulated other comprehensive loss (